France's Finance ​Ministry said on Monday it had received no formal request for investment approval ‌regarding French biotech ...

Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.

Jan 12 (Reuters) - France's ‌Finance ​Ministry said on Monday it ‌had received no formal request for investment approval ...

Eli Lilly’s presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical ...

Eli Lilly declined to comment on business development activity, and Abivax did not immediately respond to Pharmaceutical ...

Investing.com -- Eli Lilly is preparing to offer €15 billion to acquire French biotech company Abivax, according to a Monday report from La Lettre. The U.S. pharmaceutical giant has not yet submitted ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is among the 20 Best Performing Stocks in 2025. According to a story in the ...

Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the ...

Abivax (ABVX) stays a Buy as obefazimod UC data fuels multi‑billion potential; 2026 Phase 3/NDA catalysts loom and M&A ...

French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...

Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...

Abivax SA’s shares pared gains after France’s finance ministry said it has not been contacted by Eli Lilly & Co about a ...